Please check your internet connection and try again.
# Hyoscine butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is a quaternary ammonium derivative of scopolamine. It acts as an antimuscarinic/anticholinergic agent, primarily affecting smooth muscle in the gastrointestinal and genitourinary tracts. It has limited systemic absorption when taken orally and generally does not cross the blood-brain barrier, leading to fewer central nervous system side effects compared to atropine or scopolamine.
## Primary Indications
* Symptomatic relief of abdominal pain and cramping associated with gastrointestinal conditions such as irritable bowel syndrome (IBS) and diverticular disease.
* Premedication for diagnostic procedures to reduce smooth muscle spasm.
* Management of ureteric colic.
## Adult Dosing
* **Oral:** 10-20 mg up to four times daily. The maximum daily dose is typically 80 mg.
* **Intramuscular/Intravenous:** 20 mg every 4-6 hours as needed. Maximum daily dose is typically 100 mg. Dosing for IV administration in acute settings may vary based on clinical judgment and local protocols.
## Pediatric Dosing
Dosing in children is less well-established and should be guided by clinical judgment and specific product labeling.
* **Oral:** Generally not recommended for children under 6 years old. For children aged 6-12 years, 10 mg up to three times daily may be considered.
* **Intramuscular/Intravenous:** Use in children is typically reserved for specific indications and requires careful consideration of risk versus benefit. Refer to specialized pediatric formularies or expert consultation.
## Dose Adjustments
No specific dose adjustments are routinely required for hepatic or renal impairment due to limited systemic absorption and metabolism. However, caution is advised in patients with severe hepatic or renal dysfunction.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any excipients in the formulation.
* Myasthenia gravis.
* Tachyarrhythmias.
* Prostatic hypertrophy with urinary retention.
* Ileus, intestinal atony, toxic megacolon.
* Narrow-angle glaucoma.
* Pyloric stenosis and achalasia.
## Adverse Effects
Common adverse effects are generally mild and antimuscarinic in nature:
* Dry mouth
* Tachycardia
* Blurred vision
* Urinary retention
* Constipation
* Skin reactions (rash, urticaria)
Rarely, more severe reactions such as anaphylaxis, dyspnea, and facial edema can occur, particularly with parenteral administration.
## Key Drug Interactions
* **Other Anticholinergic Agents:** Additive effects may increase the risk of adverse effects (e.g., atropine, some antihistamines, tricyclic antidepressants).
* **Dopamine Antagonists:** May reduce the efficacy of prokinetic drugs like metoclopramide.
* **Gastrointestinal Motility Agents:** May antagonize the effects of agents that increase GI motility.
## Monitoring
* Monitor for resolution of abdominal pain and cramping.
* Observe for anticholinergic side effects, especially in elderly patients or those with co-existing conditions.
* Assess for signs of urinary retention, particularly in men with prostatic hypertrophy.
## Clinical Pearls
* Oral formulations have limited bioavailability and primarily exert local effects in the GI tract.
* Parenteral administration leads to more rapid and pronounced systemic effects.
* While generally considered safe, caution is warranted in the elderly and in patients with specific medical conditions contraindicating anticholinergic use.
* For severe, acute colic, parenteral administration may be preferred for faster relief.
***
*This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and local protocols before administering any medication.*
